- The Dish’s Weekly Biotechnology News Wrap Up – April 21, 2017Posted 4 days ago
- Glycosylation Overview and How to Control Glycosylation using In Vitro GlycoengineeringPosted 6 days ago
- A Novel Approach for Expansion of High Quality Mesenchymal Stem CellsPosted 7 days ago
- Cell Therapy Clinical Trials: Navigating the operational shift from Phase 1 to Phase 2Posted 1 week ago
- The Dish’s Weekly Biotechnology News Wrap Up – April 14, 2017Posted 2 weeks ago
- GMP Proteins for Cell Therapy Manufacturing: Top 6 Things to KnowPosted 2 weeks ago
- Smart Cell Culture Monitoring – Transforming the way we look at cells in culturePosted 2 weeks ago
- A Primer on Primary Cells and CulturePosted 2 weeks ago
- The Importance of Resin Selection in Development of a Platform Bioprocess FilmPosted 2 weeks ago
- The Dish’s Weekly Biotechnology News Wrap Up – April 7, 2017Posted 3 weeks ago
More Business News
CHO Cells – The Top Expression System of Best Selling Biologic Drugs
In a previous Cell Culture Dish blog, titled “Chinese Hamster Ovary (CHO) Cells –...
- Posted January 11, 2012
Amgen, Biogen Idec, and Baxter Invest in Biogenerics Industry Despite Lack of FDA Guidelines for Approval
The Affordable Care Act was approved in 2010 with the goal of reducing healthcare...
- Posted December 29, 2011
Geron Stops Stem Cell Trial to Focus on Cancer Therapies
Geron announced on Tuesday morning that they would not be enrolling new patients in...
- Posted November 18, 2011
Takeda Brings Cell Based Influenza Vaccine Production to Japan with Baxter’s Assistance
Takeda Pharmaceutical Company (Japan) recently announced they have received a 23.9 billion yen subsidy...
- Posted September 30, 2011
Aastrom Plans for the Next Step
Aastrom, a cellular therapy company in Michigan, has finalized plans for a Phase III...
- Posted September 1, 2011